Nobody knew how to even begin to predict the number of people who would register for the first-ever virtual annual meeting of the American Association for Cancer Research.
The COVID-19 pandemic will change the structure and economics of clinical care and clinical trials in cancer, said Howard “Skip” Burris, president of clinical operations and chief medical officer of Sarah Cannon, the Cancer Institute of HCA Healthcare.
Patients with lung cancer and a history of pneumonitis are more likely to develop treatment-associated pneumonitis later, especially in the course of receiving immune checkpoint inhibitor therapy, according to a new study by Syapse, FDA, and Advocate Aurora Health.
In the past, few patients had Oliver Sartor’s personal cell phone number.
At least for now, Feist-Weiller Cancer Center at the Louisiana State University Health Sciences Center at Shreveport has repurposed the three vans that were used to provide cancer screening and essential health care to medically underserved communities.
After a series of global epidemics, Don Berry has spent the past several years preparing for a serious pandemic that would be caused by yet another viral pathogen.
News coverage of the COVID-19 pandemic in New York has lent urgency to social distancing efforts in San Antonio and South Texas, likely flattening the curve.
How has the COVID-19 pandemic affected oncology?
In Italy, the number of people dying from COVID-19 has dropped to about 500 per day—a decrease from the 900 to 1,000 patients who had been dying daily when the disease spread was at its peak.
While the world watched the pandemic unfold in China and Italy, SARS-Cov-2 spread exponentially in Spain, killing more people faster and earlier within a month, relative to many outbreaks in other Western countries.
